share_log

Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Acrivon Therapeutics | 8-K: Current report

Acrivon Therapeutics | 8-K:重大事件
SEC announcement ·  03/28 08:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息